I have been working on
NMN (nicotinamide mononucleotide) therapy since last year.
After studying various things,
I have come to understand the existence of things that interfere with the action of NMN.
That’s CD38, the inflammatory response.
Chronic inflammatory conditions have long been known to be one of the major causes of aging.
In particular, it has been attracting attention from
the perspective of the aggravation of the elderly due to COVID-19 infection for the last few years.
Therefore, at our clinic,
human-derived mesenchymal stem cell culture supernatant (exosomes) therapy
suppresses inflammation and
prevents the decomposition of NAD+ (nicotinamide adenine dinucleotide) from progressing.
From this month,
our clinic has started a double therapy for healthy life expectancy, in which
human-derived mesenchymal stem cell culture supernatant (exosomes) is administrated
following NMN infusion therapy.